Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 14;19(1):32.
doi: 10.1186/s12979-022-00288-7.

Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity

Affiliations
Review

Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity

Bart N Ford et al. Immun Ageing. .

Abstract

The aging process can have detrimental effects on the immune system rendering the elderly more susceptible to infectious disease and less responsive to vaccination. Major depressive disorder (MDD) has been hypothesized to show characteristics of accelerated biological aging. This raises the possibility that depressed individuals will show some overlap with elderly populations with respect to their immune response to infection and vaccination. Here we provide an umbrella review of this literature in the context of the SARS CoV-2 pandemic. On balance, the available data do indeed suggest that depression is a risk factor for both adverse outcomes following COVID-19 infection and for reduced COVID-19 vaccine immunogenicity. We conclude that MDD (and other major psychiatric disorders) should be recognized as vulnerable populations that receive priority for vaccination along with other at-risk groups.

Keywords: Aging; Depression; Immunosenescence; Inflammaging; Psychiatric disorders; SARS CoV-2; Vaccine immunogenicity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

Cited by

References

    1. Sadighi Akha AA. Aging and the immune system: an overview. J Immunol Methods. 2018;463:21–26. doi: 10.1016/j.jim.2018.08.005. - DOI - PubMed
    1. Morrisette-Thomas V, Cohen AA, Fülöp T, Riesco É, Legault V, Li Q, et al. Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech Ageing Dev. 2014;139:49–57. doi: 10.1016/j.mad.2014.06.005. - DOI - PMC - PubMed
    1. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505–522. doi: 10.1038/s41569-018-0064-2. - DOI - PMC - PubMed
    1. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245–270. doi: 10.1146/annurev.med.51.1.245. - DOI - PubMed
    1. Varadhan R, Yao W, Matteini A, Beamer BA, Xue Q-L, Yang H, et al. Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. J Gerontol A Biol Sci Med Sci. 2014;69(2):165–173. doi: 10.1093/gerona/glt023. - DOI - PMC - PubMed

LinkOut - more resources